+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differential gel-based proteomic approach for cancer biomarker discovery using human plasma



Differential gel-based proteomic approach for cancer biomarker discovery using human plasma



Methods in Molecular Biology 854: 223-237



Two-dimensional fluorescence difference gel electrophoresis (2D DIGE) has become a general platform for analysis of various clinical samples such as biofluids and tissues. In comparison to conventional 2-D polyacrylamide gel electrophoresis (2D PAGE), 2D DIGE offers several advantages, such as accuracy and reproducibility between experiments, which facilitate spot-to-spot comparisons. Although whole plasma can be easily obtained, the complexity of plasma samples makes it challenging to analyze samples with good reproducibility. Here, we describe a method for decreasing protein complexity in plasma samples within a narrow pH range by depleting high-abundance plasma proteins. In combination with analysis of differentially expressed spots, trypsin digestion, identification of protein by mass spectrometry, and standard 2D PAGE and DIGE, this method has been optimized for comparison of plasma samples from healthy donors and patients diagnosed with hepatocellular carcinoma.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052612252

Download citation: RISBibTeXText

PMID: 22311764

DOI: 10.1007/978-1-61779-573-2_16


Related references

Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Molecular and Cellular Proteomics 5(1): 157-171, 2005

Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach. Cancer Epidemiology, Biomarkers & Prevention 16(10): 1915-1917, 2007

Proteomic profiling of human plasma for cancer biomarker discovery. Proteomics 17(6), 2016

Time course proteomic profiling of human myocardial infarction plasma samples: an approach to new biomarker discovery. Clinica Chimica Acta; International Journal of Clinical Chemistry 412(11-12): 1086-1093, 2012

Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. Plos One 4(11): E7916, 2010

Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. Journal of Proteome Research 2014, 2014

A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS. Molecular and Cellular Biochemistry 343(1-2): 91-99, 2011

A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation. Journal of Biomedicine and Biotechnology 2010: 927917, 2010

Proteomic approaches for cancer biomarker discovery in plasma. Expert Review of Proteomics 4(5): 589-590, 2007

Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Science 98(2): 201-213, 2007

Utilizing human blood plasma for proteomic biomarker discovery. Journal of Proteome Research 4(4): 1073-1085, 2005

Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry. Journal of Proteome Research 15(2): 389-399, 2016

Solvent interaction analysis as a proteomic approach to structure-based biomarker discovery and clinical diagnostics. Expert Review of Proteomics 13(1): 9-17, 2016

Discovery of urinary biomarker candidates for prostate cancer based on proteomic analyses. European Urology Suppl.s 13(1): e202-e202a, 2014

An application of the 2-nitrobenzenesulfenyl method to proteomic profiling of human colorectal carcinoma: A novel approach for biomarker discovery. Proteomics. Clinical Applications 2(6): 925-935, 2008